AN2 Therapeutics Inc (ANTX)
2.265
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
2.265
0.00 (0.00%)
Pre-Market: 20:00
AN2 Therapeutics Price to Book Value: 0.6122 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 0.6122 |
| May 16, 2024 | 0.6122 |
| May 15, 2024 | 0.6122 |
| May 14, 2024 | 0.623 |
| May 13, 2024 | 0.6338 |
| May 10, 2024 | 0.6527 |
| May 09, 2024 | 0.6662 |
| May 08, 2024 | 0.6581 |
| May 07, 2024 | 0.6878 |
| May 06, 2024 | 0.6985 |
| May 03, 2024 | 0.6905 |
| May 02, 2024 | 0.6851 |
| May 01, 2024 | 0.6473 |
| April 30, 2024 | 0.6473 |
| April 29, 2024 | 0.6392 |
| April 26, 2024 | 0.6257 |
| April 25, 2024 | 0.6149 |
| April 24, 2024 | 0.6473 |
| April 23, 2024 | 0.6392 |
| April 22, 2024 | 0.6362 |
| April 19, 2024 | 0.6659 |
| April 18, 2024 | 0.6416 |
| April 17, 2024 | 0.6686 |
| April 16, 2024 | 0.6659 |
| April 15, 2024 | 0.674 |
| Date | Value |
|---|---|
| April 12, 2024 | 0.7387 |
| April 11, 2024 | 0.8088 |
| April 10, 2024 | 0.8196 |
| April 09, 2024 | 0.8222 |
| April 08, 2024 | 0.8115 |
| April 05, 2024 | 0.8115 |
| April 04, 2024 | 0.8762 |
| April 03, 2024 | 0.9085 |
| April 02, 2024 | 0.9166 |
| April 01, 2024 | 1.014 |
| March 28, 2024 | 0.7759 |
| March 27, 2024 | 0.7687 |
| March 26, 2024 | 0.7449 |
| March 25, 2024 | 0.7663 |
| March 22, 2024 | 0.795 |
| March 21, 2024 | 0.7902 |
| March 20, 2024 | 0.7663 |
| March 19, 2024 | 0.7329 |
| March 18, 2024 | 0.7043 |
| March 15, 2024 | 0.7162 |
| March 14, 2024 | 0.725 |
| March 13, 2024 | 0.7107 |
| March 12, 2024 | 0.6917 |
| March 11, 2024 | 0.7036 |
| March 08, 2024 | 0.6988 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6122
Minimum
May 15 2024
5.443
Maximum
Sep 29 2023
2.407
Average
2.098
Median
Price to Book Value Benchmarks
| Revance Therapeutics Inc | -- |
| Viking Therapeutics Inc | 7.911 |
| VYNE Therapeutics Inc | 0.4827 |
| Aquestive Therapeutics Inc | -- |
| Humacyte Inc | 28.82 |
Price to Book Value Related Metrics
| Price | 2.265 |
| Earnings Yield | -114.1% |
| Market Cap | 67.71M |